Clinical trial

Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)

NCT01214759

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE4

Study timeline

Study start (unknown)2011-05-01Date precision: month

Registry last updated2016-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

TruvadaDRUG · verified · RxNorm: Truvada

RaltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

The University of Texas Health Science Center, Houstonlead sponsor

Merck Sharp & Dohme LLCcollaborator

Gilead Sciencescollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01214759 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.